Clinical Manifestations and Treatment Outcomes of Eosinophilic Gastroenteritis in Children
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: The aim of the present study was to investigate the clinical features and outcome of eosinophilic gastro-enteritis (EGE) in children.Methods: Our study enrolled 24 children who were diagnosed with EGE from 1993 to 2014 at the Department of Pediatrics, Seoul National University Children’s Hospital. The patients’ clinical manifestations, treatments, and out-comes were reviewed from the medical records.Results: The mean age at diagnosis was 5.3 years. Most patients had gastrointestinal symptoms including diarrhea (54.2%) and abdominal pain (45.8%). Peripheral eosinophilia was present in 91.7% of the patients. Thirteen patients (54.2%) showed anemia, and 15 patients (62.5%) had hypoalbuminemia. EGE was classified as mucosal, sub-serosal, or muscular in 75.0%, 20.8%, and 4.2% of cases, respectively. Three patients showed gastroduodenal ulcers upon endoscopic analysis. A history of allergy was reported in 13 patients, including atopic dermatitis, allergic rhinitis, and asthma. Five patients (20.8%) improved with food restrictions. Among the 19 patients treated with steroids, 11 (57.9%) discontinued steroid treatment without subsequent relapse, 4 (21.1%) relapsed after ceasing steroid treat-ment, and 4 (21.1%) showed no response to steroids. Two patients who were resistant to steroids underwent ther-apeutic surgery. The presence of gastroduodenal ulcers was significantly associated with relapse and steroid resistance.Conclusion: A high suspicion of EGE is warranted when children have nonspecific gastrointestinal symptoms and peripheral eosinophilia. Most patients improved with food restrictions or steroid treatment, although one-third of pa-tients showed a relapse or steroid resistance.
Abstract
Purpose: The aim of the present study was to investigate the clinical features and outcome of eosinophilic gastro-enteritis (EGE) in children.Methods: Our study enrolled 24 children who were diagnosed with EGE from 1993 to 2014 at the Department of Pediatrics, Seoul National University Children’s Hospital. The patients’ clinical manifestations, treatments, and out-comes were reviewed from the medical records.Results: The mean age at diagnosis was 5.3 years. Most patients had gastrointestinal symptoms including diarrhea (54.2%) and abdominal pain (45.8%). Peripheral eosinophilia was present in 91.7% of the patients. Thirteen patients (54.2%) showed anemia, and 15 patients (62.5%) had hypoalbuminemia. EGE was classified as mucosal, sub-serosal, or muscular in 75.0%, 20.8%, and 4.2% of cases, respectively. Three patients showed gastroduodenal ulcers upon endoscopic analysis. A history of allergy was reported in 13 patients, including atopic dermatitis, allergic rhinitis, and asthma. Five patients (20.8%) improved with food restrictions. Among the 19 patients treated with steroids, 11 (57.9%) discontinued steroid treatment without subsequent relapse, 4 (21.1%) relapsed after ceasing steroid treat-ment, and 4 (21.1%) showed no response to steroids. Two patients who were resistant to steroids underwent ther-apeutic surgery. The presence of gastroduodenal ulcers was significantly associated with relapse and steroid resistance.Conclusion: A high suspicion of EGE is warranted when children have nonspecific gastrointestinal symptoms and peripheral eosinophilia. Most patients improved with food restrictions or steroid treatment, although one-third of pa-tients showed a relapse or steroid resistance.
참고문헌 (25)
- Klein NC, "Eosinophilic gastroenteritis", Medicine (Baltimore), 49, pp.299~319 (1970)
- Talley NJ, "Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues", Gut, 31, pp.54~58 (1990)
- Méndez-Sánchez N, "Eosinophilic gastroenteritis: a review", Dig Dis Sci, 52, pp.2904~2911 (2007)
- Chen MJ, "Eosinophilic gastroenteritis: clinical experience with 15 patients", World J Gastroenterol, 9, pp.2813~2816 (2003)
- Kelly KJ, "Eosinophilic gastroenteritis", J Pediatr Gastroenterol Nutr, 30(Suppl), pp.S28~35 (2000)
- Lowichik A, "A quantitative evaluation of mucosal eosinophils in the pediatric gastrointestinal tract", Mod Pathol, 9, pp.110~114 (1996)
- Lee CM, "Eosinophilic gastroenteritis: 10 years experience", Am J Gastroenterol, 88, pp.70~74 (1993)
- Whitington PF, "Eosinophilic gastroenteropathy in childhood", J Pediatr Gastroenterol Nutr, 7, pp.379~385 (1988)
- Cello JP, "Eosinophilic gastroenteritis--a complex disease entity", Am J Med, 67, pp.1097~1104 (1979)
- Pineton de Chambrun G, "Natural history of eosinophilic gastroenteritis", Clin Gastroenterol Hepatol, 9, pp.950~956 (2011)
- Lee MS, "Serum IgE standardized for age in Korean children and its diagnostic reliability in childhood asthma", J Korean Pediatr Soc, 39, pp.397~403 (1996)
- Tien FM, "Clinical features and treatment responses of children with eosinophilic gastroenteritis", Pediatr Neonatol, 52, pp.272~278 (2011)
- Redondo-Cerezo E, "Eosinophilic gastroenteritis:our recent experience: one-year experience of atypical onset of an uncommon disease", Scand J Gastroenterol, 36, pp.1358~1360 (2001)
- Kalantar SJ, "Dyspepsia due to eosinophilic gastroenteritis", Dig Dis Sci, 42, pp.2327~2332 (1997)
- Khan S, "Eosinophilic gastroenteritis", Best Pract Res Clin Gastroenterol, 19, pp.177~198 (2005)
- Khan S, "Eosinophilic gastroenteritis masquerading as pyloric stenosis", Clin Pediatr (Phila), 39, pp.55~57 (2000)
- Yun MY, "Eosinophilic gastroenteritis presenting as small bowel obstruction: a case report and review of the literature", World J Gastroenterol, 13, pp.1758~1760 (2007)
- Yamaguchi Y, "Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor", J Exp Med, 167, pp.1737~1742 (1988)
- Yan BM, "Primary eosinophilic disorders of the gastrointestinal tract", Gut, 58, pp.721~732 (2009)
- Pineton de Chambrun G, "Eosinophilic enteritis", Dig Dis, 33, pp.183~189 (2015)
- DeBrosse CW, "Allergy and eosinophil-associated gastrointestinal disorders (EGID)", Curr Opin Immunol, 20, pp.703~708 (2008)
- Yamada Y, "Eosinophilic gastroenteritis treated with a multiple-food elimination diet", Allergol Int, 63(Suppl 1), pp.53~56 (2014)
- Lucendo AJ, "Efficacy of dietary treatment for inducing disease remission in eosinophilic gastroenteritis", J Pediatr Gastroenterol Nutr, 61, pp.56~64 (2015)
- Quack I, "Eosinophilic gastroenteritis in a young girl--long term remission under Montelukast", BMC Gastroenterol, 5, pp.24~ (2005)
- Schwartz DA, "Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis", Dig Dis Sci, 46, pp.1787~1790 (2001)